DAIICHI SANKYO PORTUGAL secures contract for Direct Adjustment For Acquisition Of T1823 - Trastuzumab Deruxtecan [100 Mg; Conc Sol Inj Powder; Frs]

Portugal, May 19 -- Portugal based DAIICHI SANKYO PORTUGAL has secured contract from Unidade Local De Saude De Santo Antonio, E. P. E. for Direct Adjustment For Acquisition Of T1823 - Trastuzumab Deruxtecan [100 Mg; Conc Sol Inj Powder; Frs]. The value of the contract is worth 115200000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....